Key market opportunities include smart technologies like NFC labels, advances in biologics requiring specialized packaging, and innovations in sustainable and child/senior-friendly designs ...
Future Market Insights (FMI) projects, the Dropper System Market is estimated at USD 72.9 billion in 2025 and is forecast to climb to USD 121.1 billion by 2035, expanding at a 5.2% CAGR. Growth is ...
On February 3, Bio-Thera Solutions signed a licensing and commercialization agreement with Saudi Arabia-based Avalon Pharma, granting it exclusive rights to commercialize BAT3306, a pembrolizumab ...
Mutual of Omaha continues to expand its application programming interface (API) integration offerings for benefits ...
MYQORZO® Approved for Adults with Symptomatic Obstructive HCM in U.S., China and Europe; U.S. Launch Underway with First Prescriptions Dispensed within Days of Drug Availability Supplemental NDA for ...
At this year’s J.P. Morgan Healthcare Conference, the largest healthcare investment symposium in the industry, it is no surprise that artificial intelligence featured prominently across a wide range ...
Three local nonprofits will be up nearly $12,000 in funding if the New Albany City Council votes to distribute some of the ...
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is ...
GlucaPharm is developing GEP44, a novel, patented peptide (similar in function to Ozempic, Wegovy, Mounjaro, but with reduced risk of adverse events) discovered by researchers at Syracuse University.V ...
GlucaPharm is developing GEP44, a novel, patented peptide (similar in function to Ozempic®, Wegovy®, Mounjaro®, but with reduced risk of adverse events) discovered by researchers at ...
HISTORIC LAUNCH TO LOWER DRUG PRICES FOR AMERICAN PATIENTS: Today, President Donald J. Trump announced the launch of TrumpRx.gov. Through the website, patients will be able to access large discounts ...